Compare PTCT & CIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | CIG |
|---|---|---|
| Founded | 1998 | 1952 |
| Country | United States | Brazil |
| Employees | N/A | 5384 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.0B |
| IPO Year | 2006 | N/A |
| Metric | PTCT | CIG |
|---|---|---|
| Price | $82.28 | $2.08 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $80.65 | N/A |
| AVG Volume (30 Days) | 2.2M | ★ 7.9M |
| Earning Date | 05-07-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 6.73% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.70 | $4.49 |
| P/E Ratio | ★ N/A | $9.38 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $1.79 |
| 52 Week High | $87.50 | $2.76 |
| Indicator | PTCT | CIG |
|---|---|---|
| Relative Strength Index (RSI) | 65.15 | 44.25 |
| Support Level | $73.41 | $2.02 |
| Resistance Level | $87.27 | $2.15 |
| Average True Range (ATR) | 3.11 | 0.05 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 75.57 | 33.33 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Cia Energetica DE Minas Gerais - Cemig is a Brazilian energy company engaged in the generation, transmission, distribution, and commercialization of electricity, as well as natural gas distribution. The company operates through six segments: Generation, Transmission, Trading, Distribution, Gas, and Investees. Its activities include power generation mainly from hydroelectric sources, operation and maintenance of transmission and distribution infrastructure, electricity sales to captive and free-market customers, and gas distribution in Minas Gerais. The company derives a majority of its revenue from the Distribution segment, which comprises the distribution and sale of electricity to captive customers, and the operation and maintenance of infrastructure and related services.